Just what exactly have you identified as positives for OXBT. They have been around under various name changes since 1967 and have NEVER had even one profitable quarter. They walked away from their clinical trials in the US rather than address concerns of the FDA. They exist through the dumping of tons of shares into the market diluting shareholder value in the process. Their PPS graph is a many year pattern of loss. Please, tell me what positives you see in this dire picture.